β-adrenergic agonists and especially β-2 adrenergic agonists are generally prescribed for all asthmatics as a backup medication to anti-inflammatory therapy or, in the case of exercise-induced asthma, as the primary drug. Technological advances have led to the development of increased β-2-specific adrenergic agonists of longer duration of action. The effectiveness of β-adrenergic agonists in treating asthma is indisputable. However, the very effectiveness of these drugs causes problems of overuse and consequent side effects raising such issues as whether other drugs or other parameters should be preferentially utilized.
KeywordsAdrenergic Agonist Dose Inhaler Asthma Death Injectable Route Adrenergic Drug
Unable to display preview. Download preview PDF.
- Drugs for asthma. The Med Let 1995; 37: 1–4.Google Scholar